JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jan, C.-R.
Right arrow Articles by Tseng, C.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jan, C.-R.
Right arrow Articles by Tseng, C.-J.

Vol. 294, Issue 1, 96-102, July 2000

MK-886, a Leukotriene Biosynthesis Inhibitor, as an Activator of Ca2+ Mobilization in Madin-Darby Canine Kidney (MDCK) Cells1

Chung-Ren Jan and Ching-Jiunn Tseng

Department of Medical Education and Research, Veterans General Hospital-Kaohsiung (C.-R.J., C.-J.T.); and Department of Biology and Institute of Life Sciences, National Sun Yat-sen University (C.-R.J.), Kaohsiung, Taiwan

The effect of 3-[1-(p-chlorobenzyl)-5-(isopropyl)-3-tert-butylthioindol-2-yl]-2, 2-dimethylpropanoic acid (MK-886), a leukotriene biosynthesis inhibitor, on Ca2+ mobilization in Madin- Darby canine kidney cells has been examined by fluorimetry using fura-2 as a Ca2+ indicator. MK-886 at 0.5 to 25 µM concentration dependently increased [Ca2+]i. The [Ca2+]i increase comprised an immediate initial rise and a slowly decaying phase. Ca2+ removal inhibited the Ca2+ signals by reducing both the initial rise and the decay phase, suggesting that MK-886 activated Ca2+ influx and Ca2+ release. In Ca2+-free medium, 10 µM MK-886 still increased [Ca2+]i after pretreatment with carbonylcyanide m-chlorophenylhydrazone (CCCP; 2 µM), a mitochondrial uncoupler, and thapsigargin (1 µM), an endoplasmic reticulum Ca2+ pump inhibitor. Conversely, pretreatment with MK-886 abolished CCCP- and thapsigargin-induced Ca2+ release. This suggests that 10 µM MK-886 released Ca2+ from the endoplasmic reticulum, mitochondria, and other stores. The addition of 3 mM Ca2+ increased [Ca2+]i after pretreatment with 10 µM MK-886 for 700 s in Ca2+-free medium, indicating that MK-886 induced capacitative Ca2+ entry. This capacitative Ca2+ entry was partly inhibited by SKF96365 (50 µM), by econazole (25 µM), and by inhibiting phospholipase A2 with aristolochic acid (40 µM) but not by inhibiting phospholipase D with 0.1 mM propranolol. MK-886 (10 µM)-induced Ca2+ release was not altered by inhibiting phospholipase C with U73122 (2 µM) but was inhibited by 50% by suppressing phospholipase D and phospholipase A2 with propranolol (0.1 mM) and aristolochic acid (40 µM), respectively.


1 This work was supported by grants from the National Science Council (NSC88-2314-B-075B-003), Veterans General Hospital-Kaohsiung (VGHKS89-13), and VTY Joint Research Program, Tsou's Foundation (VTY88-P3-24) to C.-R.J.


0022-3565/00/2941-0096$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
S. A. Kempson, J. M. Edwards, and M. Sturek
Inhibition of the renal betaine transporter by calcium ions
Am J Physiol Renal Physiol, August 1, 2006; 291(2): F305 - F313.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.